Skip to main content
Skip to footer
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Reach out
Category:
News
Inflammatix begins trial evaluating mRNA test for patient infection status
November 12, 2024
Inflammatix Adds MedTech Veteran as First General Counsel
October 10, 2024
Inflammatix Raises $57M in Series E Financing
September 12, 2024
Inflammatix collects $57M as it awaits FDA review of infectious disease test
September 12, 2024
Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million
September 12, 2024
Rapid Tests Continue Push Into Sepsis Market in 2023 as Competition Heats Up
January 2, 2024
Inflammatix sepsis test scores FDA breakthrough device designation
November 28, 2023
Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test
November 28, 2023
Your medical devices are getting smarter. Can the FDA keep them safe?
October 9, 2023
Point-of-care testing for infectious diseases in emergency settings
January 18, 2023
←
1
2
3
4
5
…
8
→
November 12, 2024October 10, 2024September 12, 2024September 12, 2024September 12, 2024January 2, 2024November 28, 2023November 28, 2023October 9, 2023January 18, 2023
